Reference
All 125 peptides
Every profile uses the same structure: summary, benefits and side effects, vials and reconstitution, a phase-by-phase dosing table, lifestyle notes, identification and linked research.
20 results
GHK-Cu (Copper Peptide)
Copper Peptide
GHK-Cu is a regenerative powerhouse peptide that rebuilds collagen, accelerates wound healing, and triggers anti-aging effects by remodeling skin at the genetic level. The copper component acts as a critical cofactor for enzymes responsible for collagen cross-linking—making collagen strong and flexible—while GHK itself signals cells to produce new collagen, elastin, and other structural proteins.
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 8–12 weeks
Glow – BPC-157, TB-500, GHK-Cu
Glow is a premium combination formula blending three powerhouse peptides: BPC-157 for localized tissue repair and gut healing, TB-500 for systemic recovery and inflammation control, and GHK-Cu for collagen regeneration and skin rejuvenation. Together, they create a synergistic healing effect that addresses both deep tissue repair and surface-level skin radiance.
- Route
- Subcutaneous
- Dose
- 100 mcg – 3 mg
- Cycle
- 8–12 weeks
KPV (Ac-KPV-NH2)
Ac-KPV-NH2
KPV is a tiny three-amino-acid peptide derived from alpha-MSH that acts as a precision anti-inflammatory tool, calming dangerous inflammation at its source without suppressing your immune system’s ability to fight infections. It works by blocking NF-κB, the master switch that turns on inflammatory cascade reactions, while also reducing production of pro-inflammatory cytokines like TNF-α and IL-6.
- Route
- Subcutaneous
- Dose
- 200 mcg – 500 mcg
- Cycle
- 8–12 weeks
Acetyl Hexapeptide-3 (Argireline)
Argireline · Acetyl Hexapeptide-3
Research Goal: Evaluate the non-invasive reduction of muscle contraction-induced skin wrinkling via inhibition of the SNARE complex.
- Route
- Topical
- Dose
- —
- Cycle
- 30 days for primary assessment
AHK (Tripeptide-3)
Tripeptide-3 · AHK
AHK, or Tripeptide-3, is a small hair-growth peptide that mimics natural signals in your scalp to wake up follicles and strengthen strands. It boosts blood flow and key growth factors, helping thin or shedding hair get thicker and healthier.
- Route
- Topical
- Dose
- 500 mcg – 1 mg
- Cycle
- 8–12 weeks
AHK-Cu
GHK-Cu · Copper Tripeptide-1
AHK-Cu is the copper-charged version of AHK, supercharging hair and skin repair with its metal boost. The copper helps deliver growth signals deeper, stimulating follicles for thicker, faster-growing hair while also healing wounds and reducing inflammation.
- Route
- Topical
- Dose
- —
- Cycle
- —
Decapeptide-12
Research Goal: Evaluation of melanogenesis inhibition for the treatment of melasma and post-inflammatory hyperpigmentation.
- Route
- Topical
- Dose
- —
- Cycle
- 12–16 weeks for visible pigment shift
GHK Basic
GHK Basic is a simple yet powerful tripeptide (three amino acids: glycine, histidine, and lysine) that naturally declines with age, explaining why your skin loses firmness and wounds heal slower after 40. It works by modulating gene expression to boost collagen production, suppress inflammatory signals, reduce dangerous free radicals, and activate protective antioxidant enzymes—essentially flipping the switch on your body’s self-repair programs.
- Route
- Topical
- Dose
- 2 mg – 5 mg
- Cycle
- 4–8 weeks
Matrixyl
Matrixyl is a palmitoyl-pentapeptide (five-amino-acid peptide with a fatty chain) that signals skin fibroblasts to dramatically increase collagen production and strength, reversing the collagen loss that causes wrinkles, sagging, and thin texture as you age. It works by binding to cell surface receptors and triggering signaling cascades similar to TGF-β pathways that activate collagen synthesis while simultaneously inhibiting collagen-degrading enzymes.
- Route
- Topical
- Dose
- —
- Cycle
- Minimum 60–90 days for extracellular matrix remodeling
OS-01
Peptide 14 · Peptide OS-01
OS-01 is the first peptide scientifically proven to reduce cellular senescence—the accumulation of aged, dysfunctional cells that drive visible aging and disease—by directly targeting this fundamental aging mechanism in skin. Laboratory studies show OS-01 reduces senescence marker CDKN2A by 50% in human skin samples and reversed the biological age of ex vivo skin samples by 2.5 years in just 5 days, an unprecedented achievement demonstrating genuine cellular age reversal rather than cosmetic concealment.
- Route
- Topical
- Dose
- —
- Cycle
- 12+ weeks for measurable changes in skin "biological age."
Pal-AHK
Pal-AHK is a palmitoyl-conjugated tripeptide (alanine-histidine-lysine) that dramatically stimulates collagen synthesis by activating fibroblasts through transforming growth factor-beta (TGF-β) signaling, with research suggesting up to 300% increases in collagen type I production compared to untreated controls. The palmitoyl fatty acid tail markedly improves skin penetration and cellular absorption, allowing AHK to reach deeper dermal layers where collagen synthesis occurs, far surpassing non-lipidated versions.
- Route
- Topical
- Dose
- —
- Cycle
- 8–16 weeks
Pal-GHK (Palmitoyl Tripeptide-1)
Palmitoyl Tripeptide-1
Research Goal: Analyzing the synthesis of Type I Collagen and Fibronectin in the extracellular matrix to improve skin firmness and elasticity.
- Route
- Topical
- Dose
- —
- Cycle
- 4–8 weeks for visual results
Palmitoyl Dipeptide-6
Research Goal: Investigating the structural integrity of the skin-to-muscle/fat connection and the improvement of nutrient exchange across the DEJ.
- Route
- Topical
- Dose
- —
- Cycle
- 12 weeks
Pentapeptide-18 (Leuphasyl)
Leuphasyl
Research Goal: Analyzing the inhibition of calcium influx across the neuron membrane to reduce glutamate release and muscle contraction.
- Route
- Topical
- Dose
- —
- Cycle
- 28–60 days for measurable depth reduction
Rigin (Palmitoyl Tetrapeptide-7)
Palmitoyl Tetrapeptide-7
Research Goal: Assessing the "Anti-Aging" cytokine effect to preserve collagen and elastin by mimicking the action of DHEA in the skin.
- Route
- Topical
- Dose
- —
- Cycle
- 8 weeks
SNAP-8
SNAP-8 (Acetyl Octapeptide-3) is a wrinkle-reducing peptide approximately 30% more potent than its parent peptide Argireline, working by mimicking SNAP-25 protein fragments to gently block neurotransmitter release at the neuromuscular junction, relaxing facial muscles without complete paralysis—reducing expression line depth by up to 63% within 28 days while preserving natural facial expressions.
- Route
- Subcutaneous
- Dose
- 330 mcg – 1 mg
- Cycle
- 8–12 weeks
Syn-AKE
Research Goal: Evaluation of the reversible inhibition of muscle contractions to smooth expression lines and prevent the formation of deep wrinkles.
- Route
- Topical
- Dose
- —
- Cycle
- 28–90 days for measurable topographic improvements
Syn-Coll (Palmitoyl Tripeptide-5)
Palmitoyl Tripeptide-5
Research Goal: Assessing the "Collagen Booster" effect by mimicking the human body’s own mechanism to activate latent TGF-β, leading to extracellular matrix remodeling.
- Route
- Topical
- Dose
- —
- Cycle
- 8–12 weeks
Tripeptide-29
Gly-Pro-Hyp · H-Gly-Pro-Hyp-OH
Research Goal: Assessing immediate Type I collagen increase and dermal structural density via a small-molecule peptide with high bioavailability.
- Route
- Topical
- Dose
- —
- Cycle
- 4–8 weeks
Vialox
Vialox (Pentapeptide-3) is a five-amino-acid peptide that relaxes facial muscles by blocking acetylcholine release at the neuromuscular junction, selectively binding to receptors and preventing sodium ion release—achieving 49-52% wrinkle reduction within 28 days through mechanisms similar to botulinum toxin but non-invasive and topically applied without paralysis or frozen appearance.
- Route
- Topical
- Dose
- —
- Cycle
- —